Ohh, so say something goes wrong with this next trial and it doesnt show efficiancy, could they tweak/fix it and then they would have to restart from the beginning again like preclinical rats--then to phase 1-2-3 again?They will start the trials already this autumn. However I think they are mostly doing it in the Uk. Maybe phase 3 will be in US as well but who knows. Considering that so far it has taken them around 1,5 years for a phase + planning the next one then if everything goes fine they will be finished it 5-6 years + some time to get on the market. 2025 is realistic only if they fail and have to make improvements.